Nasdaq12d
Biotech Stocks Facing FDA Decision In February 2025
(RTTNews) - February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart Month was officially declared by President Lyndon B.
Nasdaq10d
Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?
Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 9% from a peak the stock set in November, despite some highly positive news. The U.S. Food and Drug Administration (FDA) approved ...
Nasdaq27d
J&J Seeks FDA Nod for Non-Muscle Invasive Bladder Cancer Drug
Johnson & Johnson JNJ has initiated a rolling submission with the FDA seeking approval for TAR-200, its investigational drug-device combination to treat certain patients with non-muscle invasive ...
Nasdaq14d
Adial Pharmaceuticals Completes Pharmacokinetics Study of AD04, Prepares for FDA End-of-Phase 2 Interaction
We have engaged with the FDA on the results of this PK bridging ... and our ability to retain our key employees or maintain our Nasdaq listing. These risks should not be construed as exhaustive ...
Nasdaq12d
Axsome Therapeutics Receives FDA Approval for SYMBRAVO, a Novel Acute Treatment for Migraine Pain Relief
The FDA approval of SYMBRAVO for the acute treatment of migraines provides a significant new treatment option for millions of Americans suffering from this debilitating condition. SYMBRAVO ...
Nasdaq28d
Tempus Announces the National Launch of FDA-Approved xT CDx Test
Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the national launch of the company’s FDA-approved, NGS-based ...
Nasdaq16d
Alvotech: FDA To Review BLA For AVT05 - Quick Facts
The FDA review process is anticipated to be completed ... and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New ...
Nasdaq12d
VRTX Gets FDA Nod for Non-Opioid Pain Drug Journavx, Shares Up
Vertex Pharmaceuticals Incorporated VRTX announced that the FDA has approved its oral ... From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more ...
Nasdaq9d
HCW Biologics Inc. Receives FDA Clearance for IND Application to Initiate Phase 1 Clinical Trial of HCW9302 for Alopecia Areata
HCW Biologics Inc. has announced the FDA's approval of its Investigational ... HCW Biologics Inc. (“HCWB” or the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical ...
Nasdaq26d
ImmunityBio Provides Update On FDA Submissions For 2025
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...
Nasdaq15d
CLPT Stock Gains on FDA Clearance for Navigation Software Version 3.0
This signifies the first-ever FDA marketing authorization of a device ... You can see the complete list of today’s Zacks #1 Rank stocks here. VCYT’s earnings surpassed estimates in each ...
Nasdaq15d
FDA Approves Qelbree Label For ADHD And Lactation
Qelbree is now the first ADHD treatment to meet the FDA's post-marketing requirement ... the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew ...